PYXS Pyxis Oncology, Inc.

Fundamentals / CIK 0001782223 / USD

Pyxis Oncology, Inc. reported $13.86M in revenue and a net loss of $86.71M for the fiscal year ended December 31, 2025 (down 14.2% year over year), with a 82.8% gross margin and a -643.4% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open PYXS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$28.66M$14.33M$0-$114.2MFY 2020 Net Income: -$12.83M2020FY 2021 Net Income: -$75.97M2021FY 2022 Net Income: -$120.7M2022FY 2023 Net Income: -$73.79M2023FY 2024 Revenue: $16.15MFY 2024 Net Income: -$77.33M2024FY 2025 Revenue: $13.86MFY 2025 Net Income: -$79.62M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $13.86M $16.15M -- -- -- --
Cost of Revenue $2.39M $475K -- -- -- --
Gross Profit $11.47M $15.67M -- -- -- --
Research & Development $73.70M $58.75M $49.59M $86.13M $51.05M $9.05M
Total Operating Expenses -- -- $82.20M $123.5M $69.72M $12.89M
Operating Income -$84.42M -$89.46M -$82.20M -$123.5M -$69.72M -$12.89M
EBITDA -$79.91M -$86.48M -$80.27M -$122.8M -$69.07M -$12.43M
Interest Income $650K $930K $1.84M $2.76M $23K $66K
Income Before Tax -$78.23M -$79.50M -$73.79M -- -- --
Income Tax Expense $1.39M -$2.16M -- -- -- --
Net Income -$79.62M -$77.33M -$73.79M -$120.7M -$75.97M -$12.83M
Basic EPS -$1.28 -$1.32 -$1.85 -$3.65 -$8.95 -$12.45
Diluted EPS -$1.28 -$1.32 -$1.85 -$3.65 -$8.95 -$12.45
Basic Shares Outstanding 62.1M 58.4M 39.9M 33.0M 8.5M 1.0M
Diluted Shares Outstanding 62.1M 58.4M 39.9M 33.0M 8.5M 1.0M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -- -- -- -- -- $2.82M -- $0
Cost of Revenue -- -- -- -- -- -- -- $0
Gross Profit -- -- -- -- -- -- -- $0
Research & Development $16.56M $16.06M $19.98M $21.71M $17.81M $17.13M $17.04M $14.02M
Total Operating Expenses $20.52M $25.99M $24.36M -- $23.46M $22.57M $22.91M --
Operating Income -$20.52M -$25.99M -$24.36M -$18.30M -$23.46M -$19.75M -$22.91M -$40.07M
EBITDA -$20.22M -$25.69M -$23.90M -$15.40M -$22.93M -$19.21M -$22.36M -$39.52M
Interest Income $201K $61K $218K $225K $242K $99K $84K $87K
Income Before Tax -$19.98M -$25.35M -- -- -$22.00M -$18.07M -- --
Income Tax Expense $0 $0 -- -- $0 $283K -- --
Net Income -$19.98M -$25.35M -$23.27M -$18.11M -$22.00M -$18.35M -$21.16M -$35.57M
Basic EPS -$0.24 -$0.40 -$0.37 -- -$0.35 -$0.30 -$0.35 --
Diluted EPS -$0.24 -$0.40 -$0.37 -- -$0.35 -$0.30 -$0.35 --
Basic Shares Outstanding 83.5M 64.0M 63.5M -- 62.6M 61.9M 61.0M --
Diluted Shares Outstanding 83.5M 64.0M 63.5M -- 62.6M 61.9M 61.0M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $15.42M $19.47M $9.66M $179.3M $274.7M $8.08M
Short-Term Investments $51.44M $107.5M $109.6M -- -- --
Cash & Short-Term Investments $66.90M $126.9M $119.3M $179.3M $274.7M $8.08M
Other Current Assets $626K $434K $326K $381K $84K $15K
Total Current Assets $72.11M $132.4M $124.6M $186.6M $278.7M $8.10M
Property, Plant & Equipment, Net $8.00M $9.90M $11.87M $11.16M $1.01M $1.10M
Intangible Assets $0 $2.60M $24.31M -- -- --
Other Non-Current Assets -- -- -- -- $109K $109K
Total Non-Current Assets $19.41M $24.74M $49.12M $24.77M $1.35M $2.05M
Total Assets $91.52M $157.2M $173.7M $211.4M $280.0M $10.15M
Accounts Payable $10.88M $4.86M $3.90M $7.10M $11.95M $1.08M
Deferred Revenue (Current) -- -- $7.66M -- -- --
Total Current Liabilities $21.13M $17.68M $25.76M $31.63M $18.71M $3.69M
Total Non-Current Liabilities $16.98M $18.75M $22.26M $18.92M $0 $165K
Total Liabilities $38.11M $36.43M $48.02M $50.55M $18.71M $3.85M
Total Debt (incl. Leases) $18.67M $20.20M $21.33M $18.92M $165K $780K
Common Stock $63K $60K $45K $34K $32K $1.0K
Retained Earnings -$443.2M -$363.6M -$286.2M -$212.4M -$91.72M -$15.74M
Accumulated Other Comp. Income $53K $170K $63K -- -- --
Total Stockholders' Equity $53.41M $120.8M $125.7M $160.8M $261.3M -$15.64M
Total Equity $53.41M $120.8M $125.7M $160.8M $261.3M -$15.64M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $3.86M $18.86M $5.77M $15.42M $8.92M $10.73M $12.76M $19.47M
Short-Term Investments $51.72M $14.14M $35.25M $51.44M $67.34M $78.21M $92.67M $107.5M
Cash & Short-Term Investments $55.60M $33.00M $41.00M $66.90M $76.30M $88.90M $105.4M $126.9M
Accounts Receivable, Net -- -- -- -- -- $3.00M -- --
Other Current Assets -- -- -- $626K -- -- -- $434K
Total Current Assets $59.13M $36.73M $45.57M $72.11M $83.07M $99.96M $111.9M $132.4M
Property, Plant & Equipment, Net $6.94M $7.24M $7.54M $8.00M $8.46M $8.92M $9.40M $9.90M
Intangible Assets -- -- -- $0 $2.43M $2.49M $2.54M $2.60M
Total Non-Current Assets $17.64M $18.19M $18.73M $19.41M $22.53M $23.26M $24.00M $24.74M
Total Assets $76.77M $54.92M $64.30M $91.52M $105.6M $123.2M $135.9M $157.2M
Accounts Payable $8.12M $3.27M $4.99M $10.88M $9.76M $9.41M $2.85M $4.86M
Total Current Liabilities $19.94M $27.47M $16.53M $21.13M $19.38M $17.68M $14.43M $17.68M
Total Non-Current Liabilities $15.51M $16.01M $16.50M $16.98M $17.44M $17.89M $18.33M $18.75M
Total Liabilities $35.45M $43.48M $33.03M $38.11M $36.83M $35.57M $32.76M $36.43M
Total Debt (incl. Leases) $17.40M $17.83M $18.26M $18.67M $19.07M $19.46M $19.84M $20.20M
Common Stock $83K $63K $63K $63K $62K $62K $62K $60K
Retained Earnings -$511.8M -$491.8M -$466.4M -$443.2M -$425.1M -$403.1M -$384.7M -$363.6M
Accumulated Other Comp. Income -$56K -$4.0K $0 $53K $69K -$5.0K $49K $170K
Total Stockholders' Equity $41.32M $11.44M $31.27M $53.41M $68.78M $87.64M $103.1M $120.8M
Total Equity $41.32M $11.44M $31.27M $53.41M $68.78M $87.64M $103.1M $120.8M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$79.62M -$77.33M -$73.79M -$120.7M -$75.97M -$12.83M
Depreciation & Amortization $4.51M $2.98M $1.93M $709K $647K $469K
Stock-Based Compensation $11.80M $12.95M $16.95M $15.76M $6.44M $44K
Change in Payables $6.03M $1.20M -$3.51M -$8.33M $4.64M $558K
Operating Cash Flow -$63.50M -$57.67M -$70.71M -$89.33M -$35.33M -$10.08M
Capital Expenditure -$9.0K -$237K -$6.73M -$6.40M -$540K -$1.48M
Free Cash Flow -$63.51M -$57.91M -$77.44M -$95.73M -$35.87M -$11.57M
Purchases of Investments -$107.0M -$160.1M -$196.8M -- -- --
Investing Cash Flow $58.86M $8.15M -$104.8M -$6.40M -$590K -$1.48M
Common Stock Issued -- -- -- -- -- $3.0K
Financing Cash Flow $594K $59.33M $5.93M $183K $304.0M $35K
Net Change in Cash -$4.05M $9.81M -$169.6M -$95.55M $268.1M -$11.53M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$19.98M -$25.35M -$23.27M -$18.11M -$22.00M -$18.35M -$21.16M -$35.57M
Depreciation & Amortization $299K $301K $459K $2.90M $527K $535K $552K $550K
Stock-Based Compensation $1.33M $5.53M $1.21M $2.08M $3.07M $3.02M $3.63M $2.77M
Change in Payables $4.86M -$1.72M -$5.90M $1.13M $344K $6.57M -$2.01M -$10K
Operating Cash Flow -$16.29M -$18.21M -$26.00M -$10.43M -$13.28M -$17.26M -$22.54M -$19.29M
Capital Expenditure -- -- -- -- -- -- -- $0
Free Cash Flow -- -- -- -- -- -- -- -$19.29M
Purchases of Investments -$49.37M -$3.00M -$10.99M $0 -$14.56M -$41.10M -$51.35M -$4.37M
Investing Cash Flow -$37.29M $21.30M $16.37M $16.26M $11.47M $15.30M $15.82M $26.66M
Financing Cash Flow $38.59M $9.99M -$25K $669K -$8.0K -$67K $0 $50K
Net Change in Cash -$15.00M $13.09M -$9.66M $6.50M -$1.81M -$2.03M -$6.71M $7.42M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 82.8% 97.1% -- -- -- --
Operating Margin -609.2% -554.1% -- -- -- --
Net Profit Margin -574.5% -478.9% -- -- -- --
Return on Equity (ROE) -149.1% -64.0% -58.7% -75.1% -29.1% --
Return on Assets (ROA) -87.0% -49.2% -42.5% -57.1% -27.1% -126.4%
Current Ratio 3.41x 7.49x 4.84x 5.90x 14.90x 2.20x
Quick Ratio 3.17x 7.18x 4.63x 5.67x 14.69x 2.19x
Debt to Equity 0.35x 0.17x 0.17x 0.12x 0.00x --
Revenue Growth (YoY) -14.2% -- -- -- -- --
Gross Profit Growth (YoY) -26.8% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin -- -- -- -- -- -- -- 97.1%
Operating Margin -- -- -- -- -- -- -- -554.1%
Net Profit Margin -- -- -- -- -- -- -- -478.9%
Return on Equity (ROE) -209.8% -775.6% -261.4% -149.1% -141.2% -109.9% -92.4% -64.0%
Return on Assets (ROA) -112.9% -161.6% -127.1% -87.0% -91.9% -78.1% -70.1% -49.2%
Current Ratio 2.96x 1.34x 2.76x 3.41x 4.29x 5.65x 7.75x 7.49x
Quick Ratio 2.79x 1.20x 2.48x 3.17x 3.94x 5.20x 7.30x 7.18x
Debt to Equity 0.42x 1.56x 0.58x 0.35x 0.28x 0.22x 0.19x 0.17x
Source: SEC EDGAR CompanyFacts (CIK 0001782223) · from March 31, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:49 UTC · Open in terminal